Skip to content

Premature Ovarian Failure 2a C1845293

Published: July 22, 2026Updated: August 25, 2026

Premature Ovarian Failure 2a is a genetic form of ovarian dysfunction where ovaries stop working before age 40. It affects women and is managed with hormone replacement therapy and fertility support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Irregular menstrual cycles

(endocrine)

Hot flashes

(endocrine)

Vaginal dryness

(endocrine)

Joint pain

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Hormone replacement therapy (HRT)

Individualized estrogen and progestogen replacement to restore hormonal milieu, alleviate vasomotor symptoms, and protect bone and cardiovascular systems. Transdermal delivery may be preferred to minimize thrombotic risk.

medication
3

Bone health nutritional support

Comprehensive approach including calcium-rich foods, vitamin D supplementation, and avoidance of excessive caffeine, sodium, and alcohol which can negatively impact bone density.

dietary

Additional treatment options

Comprehensive endocrine monitoring

Regular assessment of FSH, estradiol levels, thyroid function, adrenal antibodies, and metabolic markers to monitor disease progression and treatment adequacy.

monitoring

Phytoestrogen and herbal supplementation

Limited evidence supports use of soy isoflavones or black cohosh for mild symptom management; however, these should not replace conventional HRT in confirmed POI.

complementary

Psychosocial support and identity counseling

Support for emotional adjustment to diagnosis, particularly given genetic associations with type 2A. Addresses impact on relationships, sexuality, and long-term life planning.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Medication Comparisons

Compare medications used to treat Premature Ovarian Failure 2a C1845293. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy